This webcast will feature content designed for the comanagement of patients with advanced diabetic retinopathy. Topics of discussion include stages of retinal disease optimal time for referral telemedicine and the importance of maintaining communication in addition to challenging case studies. Target Audience This certified COPE activity is designed for optometrists involved in the management of patients with diabetes.
Supported through an independent medical education grant from Genentech.Coordinated Care and the Complex Diabetic Retinopathy Patient
Media formats available:
Details
Presenters
Learning Objectives
This initiative is designed to address and resolve the educational needs through the following educational objectives: • Describe the increasing prevalence of diabetes and diabetic retinopathy. • Identify and implement screening guidelines for patients based on their risk factors. • Explain to patients the need for early referral to a retina specialist. • Understand advances in imaging and how these allow for earlier diagnosis of disease or disease progression. • Identify the novel therapies under investigation for the treatment of DR and DME. Accreditation
Credit Designation Statement Sponsored by: 
Evolve Medical Education LLC (Evolve) is an approved COPE administrator.
This course is COPE approved for 1.0 hours of CE Credit for Optometrists.
Course ID: 67768-PSActivity Number: 119218This educational activity is provided by Evolve Medical Education
Participation Method
Please proceed through the program, complete the post-test, evaluation and submit for credit. Faculty and Disclosures
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and resolve all conflicts of interest prior to this educational activity.Faculty:
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.Dilsher S. Dhoot, MD California Retina Consultants Retina Consultants of America Santa Barbara, CA Steven G. Ferrucci, OD, FAAO Chief Optometry Department, Sepulveda VA Medical Center Professor Southern California College of Optometry The following faculty have the following financial relationships with commercial interests:Dilsher Dhoot, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Allergan, Alimera Sciences, Bayer, Eyepoint Pharmaceuticals, Genentech, Novartis, Santen, and Regeneron Pharmaceuticals; Grant/Research: Genentech, Regeneron Pharmaceuticals; Speakers Bureau: Alimera Sciences, Eyepoint Pharmaceuticals, Genentech, Novartis, and Regeneron Pharmaceuticals; Stocks: Vortex Surgical. Steven G. Ferrucci, OD, FAAO, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Centervue, MacuLogix; Speakers Bureau: Alcon, Genentech, Optovue, and Regeneron Pharmaceuticals. Editorial Support Disclosures: The staff and planners involved in this activity have no financial relationships with commercial interests.Disclaimer
OFF-LABEL STATEMENT This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. DISCLAIMER The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, or Genentech Pharmaceuticals. System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
- Apple Safari for Mac OS and iOS
- Mozilla Firefox for Windows, Mac OS, iOS, and Android
- Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Release Date:
Expiration Date:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
Douglas K. Devries, OD
Cecelia Koetting, OD, FAAO
- MinuteCE®
The Missed Diagnosis: A 45-Year-Old Software Engineer Who Complains of Dry Eyes
1.00 program creditDouglas K. Devries, OD
Cecelia Koetting, OD, FAAO
Douglas K. Devries, OD
Cecelia Koetting, OD, FAAO
Douglas K. Devries, OD
Cecelia Koetting, OD, FAAO
